Related references
Note: Only part of the references are listed.Time to Prepare for Risk Adaptation in Lymphoma by Standardizing Measurement of Metabolic Tumor Burden
Sally E. Barrington et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
B-Cell Lymphomas, Version 3.2019 Featured Updates to the NCCN Guidelines
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
Oystein Fluge et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
END OF TREATMENT PET-CT PREDICTS PROGRESSION-FREE SURVIVAL IN DLBCL AFTER FIRST-LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY
L. Kostakoglu et al.
HEMATOLOGICAL ONCOLOGY (2017)
RADIOTHERAPY TO BULKY DISEASE PET-NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL
M. Pfreundschuh et al.
HEMATOLOGICAL ONCOLOGY (2017)
Treatment outcome of diffuse large B-cell lymphoma involving the head and neck Two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy
Yoo-Kang Kwak et al.
MEDICINE (2017)
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
U. Vitolo et al.
ANNALS OF ONCOLOGY (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Guidelines for the management of diffuse large B-cell lymphoma
Sridhar Chaganti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis
Hugo J. A. Adams et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era
Andrea K. Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Diffuse Large B-Cell Lymphoma Version 1.2016 Clinical Practice Guidelines in Oncology
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas
Sally F. Barrington et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
FDG PET/CT Response Assessment Criteria for Patients with Hodgkin's and Non-Hodgkin's Lymphoma at End of Therapy: A Multiparametric Approach
Ur Metser et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis
Chunhong Hu et al.
ACTA HAEMATOLOGICA (2015)
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
H. Tilly et al.
ANNALS OF ONCOLOGY (2015)
Benefit of Consolidative Radiation Therapy for Primary Bone Diffuse Large B-Cell Lymphoma
Randa Tao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Joachim Yahalom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Christoph Mamot et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Utility of interim and end-of-treatment [F-18]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma
Scott F. Huntington et al.
LEUKEMIA & LYMPHOMA (2015)
Radiation for Diffuse Large B-Cell Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network Lymphoma Outcomes Project
Bouthaina S. Dabaja et al.
CANCER (2015)
Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma-Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Tim Illidge et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Bulky Aggressive B-Cell Lymphoma: To Radiate or Not to Radiate-That Is the Question
Brad S. Kahl
JOURNAL OF CLINICAL ONCOLOGY (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Matthew J. Maurer et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma
Robert Carr et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Variance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings
Virendra Kumar et al.
CLINICAL NUCLEAR MEDICINE (2013)
Patterns of Failure in Advanced Stage Diffuse Large B-Cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidative Radiation Therapy
Zheng Shi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement
Gerhard Held et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
Patrizia Pregno et al.
BLOOD (2012)
Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy Involved-Field Versus Involved-Node Radiotherapy
Belinda A. Campbell et al.
CANCER (2012)
Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging
Jennifer A. Dorth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Bertrand Coiffier et al.
BLOOD (2010)
Benefit of Consolidative Radiation Therapy in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP Chemotherapy
Jack Phan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
F-18-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
Michal Weiler-Sagie et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Variability in PET quantitation within a multicenter consortium
Frederic H. Fahey et al.
MEDICAL PHYSICS (2010)
High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma
J. Y. Y. Ngeow et al.
ANNALS OF ONCOLOGY (2009)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The rationale and role of radiation therapy in the treatment of patients with diffuse large B-cell lymphoma in the Rituximab era
Andrew Wirth
LEUKEMIA & LYMPHOMA (2007)
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
K Spaepen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
